Frontiers in Immunology (May 2023)
Machine learning analysis of humoral and cellular responses to SARS-CoV-2 infection in young adults
- Ricards Marcinkevics,
- Pamuditha N. Silva,
- Anna-Katharina Hankele,
- Charlyn Dörnte,
- Sarah Kadelka,
- Katharina Csik,
- Svenja Godbersen,
- Algera Goga,
- Lynn Hasenöhrl,
- Pascale Hirschi,
- Hasan Kabakci,
- Mary P. LaPierre,
- Johanna Mayrhofer,
- Alexandra C. Title,
- Xuan Shu,
- Nouell Baiioud,
- Sandra Bernal,
- Laura Dassisti,
- Mara D. Saenz-de-Juano,
- Meret Schmidhauser,
- Giulia Silvestrelli,
- Simon Z. Ulbrich,
- Thea J. Ulbrich,
- Tamara Wyss,
- Daniel J. Stekhoven,
- Faisal S. Al-Quaddoomi,
- Shuqing Yu,
- Mascha Binder,
- Christoph Schultheiβ,
- Claudia Zindel,
- Christoph Kolling,
- Jörg Goldhahn,
- Bahram Kasmapour Seighalani,
- Polina Zjablovskaja,
- Frank Hardung,
- Marc Schuster,
- Anne Richter,
- Yi-Ju Huang,
- Gereon Lauer,
- Herrad Baurmann,
- Jun Siong Low,
- Daniela Vaqueirinho,
- Sandra Jovic,
- Luca Piccoli,
- Sandra Ciesek,
- Julia E. Vogt,
- Federica Sallusto,
- Federica Sallusto,
- Markus Stoffel,
- Markus Stoffel,
- Susanne E. Ulbrich
Affiliations
- Ricards Marcinkevics
- Department of Computer Science, ETH Zurich, Zurich, Switzerland
- Pamuditha N. Silva
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Anna-Katharina Hankele
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- Charlyn Dörnte
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
- Sarah Kadelka
- Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland
- Katharina Csik
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Svenja Godbersen
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Algera Goga
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Lynn Hasenöhrl
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Pascale Hirschi
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Hasan Kabakci
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Mary P. LaPierre
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Johanna Mayrhofer
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Alexandra C. Title
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Xuan Shu
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Nouell Baiioud
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- Sandra Bernal
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- Laura Dassisti
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- Mara D. Saenz-de-Juano
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- Meret Schmidhauser
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- Giulia Silvestrelli
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- Simon Z. Ulbrich
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- Thea J. Ulbrich
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- Tamara Wyss
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- Daniel J. Stekhoven
- NEXUS Personalized Health Technologies, Zurich & SIB Swiss Institute of Bioinformatics, ETH Zurich, Lausanne, Switzerland
- Faisal S. Al-Quaddoomi
- NEXUS Personalized Health Technologies, Zurich & SIB Swiss Institute of Bioinformatics, ETH Zurich, Lausanne, Switzerland
- Shuqing Yu
- NEXUS Personalized Health Technologies, Zurich & SIB Swiss Institute of Bioinformatics, ETH Zurich, Lausanne, Switzerland
- Mascha Binder
- Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany
- Christoph Schultheiβ
- Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany
- Claudia Zindel
- Department of Health Science, Translational Medicine, ETH Zurich, Zurich, Switzerland
- Christoph Kolling
- Department of Health Science, Translational Medicine, ETH Zurich, Zurich, Switzerland
- Jörg Goldhahn
- Department of Health Science, Translational Medicine, ETH Zurich, Zurich, Switzerland
- Bahram Kasmapour Seighalani
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
- Polina Zjablovskaja
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
- Frank Hardung
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
- Marc Schuster
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
- Anne Richter
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
- Yi-Ju Huang
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
- Gereon Lauer
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
- Herrad Baurmann
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
- Jun Siong Low
- Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland
- Daniela Vaqueirinho
- Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland
- Sandra Jovic
- Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland
- Luca Piccoli
- 0Humabs BioMed SA, a Subsidiary of Vir Biotechnology, Bellinzona, Switzerland
- Sandra Ciesek
- 1Institute of Medical Virology, Goethe University Frankfurt, Frankfurt am Main, Germany
- Julia E. Vogt
- Department of Computer Science, ETH Zurich, Zurich, Switzerland
- Federica Sallusto
- Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland
- Federica Sallusto
- 2Medical Immunology, Institute of Microbiology, ETH Zurich, Zurich, Switzerland
- Markus Stoffel
- Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- Markus Stoffel
- 3University Hospital Zurich, Zurich, Switzerland
- Susanne E. Ulbrich
- Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland
- DOI
- https://doi.org/10.3389/fimmu.2023.1158905
- Journal volume & issue
-
Vol. 14
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces B and T cell responses, contributing to virus neutralization. In a cohort of 2,911 young adults, we identified 65 individuals who had an asymptomatic or mildly symptomatic SARS-CoV-2 infection and characterized their humoral and T cell responses to the Spike (S), Nucleocapsid (N) and Membrane (M) proteins. We found that previous infection induced CD4 T cells that vigorously responded to pools of peptides derived from the S and N proteins. By using statistical and machine learning models, we observed that the T cell response highly correlated with a compound titer of antibodies against the Receptor Binding Domain (RBD), S and N. However, while serum antibodies decayed over time, the cellular phenotype of these individuals remained stable over four months. Our computational analysis demonstrates that in young adults, asymptomatic and paucisymptomatic SARS-CoV-2 infections can induce robust and long-lasting CD4 T cell responses that exhibit slower decays than antibody titers. These observations imply that next-generation COVID-19 vaccines should be designed to induce stronger cellular responses to sustain the generation of potent neutralizing antibodies.
Keywords